Changeflow GovPing Healthcare Health Trackers for Autonomous Targeting of Tis...
Routine Notice Added Final

Health Trackers for Autonomous Targeting of Tissue Sampling Sites

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO granted patent US12599313B2 to inventor Gil Travish on April 14, 2026. The patent covers health tracker devices configured to autonomously target tissue sampling sites using magnetic resonance spectral data. The scanner includes a magnet for field gradients, RF transmitting antenna, and RF sensing antenna to obtain spectral data from predetermined locations within a volume of interest. The patent contains 14 claims and was filed on June 23, 2022.

What changed

USPTO granted patent US12599313B2 covering health tracker devices with magnetic resonance scanning capabilities for autonomously targeting tissue sampling sites. The invention includes a scanner with magnet, RF transmitting antenna, and RF sensing antenna configured to obtain spectral data from predetermined locations within a volume of interest.

For medical device manufacturers and healthcare technology developers, this patent establishes intellectual property rights in the health tracker and tissue sampling automation space. Competitors developing similar magnetic resonance-based tissue targeting systems should conduct freedom-to-operate analyses to assess potential infringement exposure.

What to do next

  1. Monitor patent portfolio for competitive intelligence
  2. Review patent claims for potential infringement analysis
  3. Consult patent counsel regarding licensing opportunities

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Health trackers for autonomous targeting of tissue sampling sites

Grant US12599313B2 Kind: B2 Apr 14, 2026

Inventors

Gil Travish

Abstract

Health trackers for targeting tissue sampling sites in accordance with embodiments of the invention are provided. In one embodiment, a health tracker includes: a scanner for capturing spectral data, the scanner comprising: a magnet configured to generate a field gradient across a region of interest; an RF transmitting antenna configured to generate a localized field; and an RF sensing antenna configured to sense a localized area; and where the scanner is configured to obtain magnetic resonance spectral data from predetermined locations with a volume of interest.

CPC Classifications

A61B 5/055 A61B 5/064 A61B 5/4244 A61B 5/4872 G01R 33/3802 G01R 33/3808 G01R 33/46 G01R 33/4828 G01R 33/383

Filing Date

2022-06-23

Application No.

17848154

Claims

14

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12599313B2
Docket
17848154

Who this affects

Applies to
Medical device makers Healthcare providers Investors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent granting Medical device IP Diagnostic equipment
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!